Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

TELA Bio Inc

TELA ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Micro Cap Analyst: BUY

Last Close

$0.64

▼ -4.97%

Market Cap $28.93M · Vol 34.32K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$28.93M

Micro Cap

Div Yield

N/A

EPS Growth

+18.10%

YoY

RSI (14)

49.58

Momentum

Beta

1.31

vs Market

52W High

$1.98

67.46% below

52W Low

$0.52

24.94% above

Volume

34.32K

Avg 26.33K

P/B

8.32

Price-to-book

ROE

N/A

Return on equity

Free Float

90.98%

Public shares

Shariah Compliance8 STANDARDS

✗ TELA Bio Inc (TELA) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does TELA pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-25.93%

-14.15%

-34.92%

-18.35%

YTD

-45.40%

-59.73%

-92.87%

-95.25%

Financials & Valuation

TTM · Annual

Total Revenue	$80.28M
Net Income	$-38,831,000.00
Revenue Growth (YoY)	-4.49%
Gross Margin	67.69%
Operating Margin	-42.05%
Net Profit Margin	-48.37%
ROE	N/A
ROA · ROIC	-45.96% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.69
P/B	8.32
P/FCF	N/A
EPS Growth	+18.10%
Outstanding Shares	44.89M

Technical Indicators

50-Day SMA	$0.79
200-Day SMA	$0.90
RSI (14)	49.58
Beta	1.31
52-Week High	$1.98
52-Week Low	$0.52

Volume Today	34.32K
Avg Daily Volume (30D)	26.33K
Relative Volume	1.30x
Volatility (10D)	149.84
Volatility (30D)	113.81
Free Float	90.98%

Analyst Consensus

BUY

Current Price $0.64

Mean Target $2.10

52W Low$0.52 52W High$1.98

Current

Target

$0.52 $1.98

Current Analyst target

+225.94% upside potential · 5 analysts

Identifiers

ExchangeNasdaq

FIGIBBG004CH7Z69

ISINUS8723811084

CountryUnited States of America

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateNov 10, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -0.02% MDT Medtronic PLC +0.76% COR Cencora Inc +1.23% 7741.T Hoya Corp +0.32% BDX Becton Dickinson and Co +0.79%

Company Profile

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.